Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:primary hyperaldosteronism
go back to main search page
Accession:DOID:446 term browser browse the term
Definition:A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
Synonyms:exact_synonym: Cushing syndrome;   Cushing's syndrome;   aldosteronism;   hyperaldosteronism;   primary aldosteronism
 primary_id: MESH:D006929
 alt_id: RDO:0004980
 xref: ICD10CM:E24;   ICD10CM:E24.9;   ICD10CM:E26;   ICD10CM:E26.9;   ICD9CM:255.0;   ICD9CM:255.1;   ICD9CM:255.10;   NCI:C113213;   NCI:C2969;   OMIM:PS103900;   ORDO:235936
For additional species annotation, visit the Alliance of Genome Resources.


show annotations for term's descendants       view all columns           Sort by:
 
primary hyperaldosteronism term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 JBrowse link 2 204,003,742 204,032,023 RGD:11554173
G Atp2b3 ATPase plasma membrane Ca2+ transporting 3 JBrowse link X 157,236,400 157,312,028 RGD:11554173
G Cacna1d calcium voltage-gated channel subunit alpha1 D JBrowse link 16 6,110,294 6,405,022 RGD:11554173
G Cacna1h calcium voltage-gated channel subunit alpha1 H JBrowse link 10 14,730,932 14,789,201 RGD:8554872
G Clcn2 chloride voltage-gated channel 2 JBrowse link 11 82,862,664 82,876,165 RGD:11554173
G Crh corticotropin releasing hormone JBrowse link 2 104,459,999 104,461,863 RGD:13592920
G Cybb cytochrome b-245 beta chain JBrowse link X 14,578,330 14,610,049 RGD:1599681
G Cyp11b1 cytochrome P450, family 11, subfamily b, polypeptide 1 RGD:4891155
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 JBrowse link 7 116,248,759 116,255,205 RGD:11554173
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 JBrowse link 7 116,155,928 116,161,781 RGD:11554173
G Drd2 dopamine receptor D2 JBrowse link 8 53,678,777 53,743,643 RGD:13592920
G Gnas GNAS complex locus JBrowse link 3 172,374,957 172,434,988 RGD:8554872
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 JBrowse link 8 33,435,493 33,463,410 RGD:13592920
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 JBrowse link 18 31,728,373 32,704,022 RGD:13592920
G Serpina1 serpin family A member 1 JBrowse link 6 127,610,241 127,632,265 RGD:1643158
Autosomal Dominant Hypocalcemia, with Bartter Syndrome term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Casr calcium-sensing receptor JBrowse link 11 67,188,204 67,262,261 RGD:8554872
RGD:11554173
Bartter disease term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Bsnd barttin CLCNK type accessory subunit beta JBrowse link 5 126,071,849 126,080,647 RGD:1600603
RGD:8554872
G Clcnkb chloride voltage-gated channel Kb JBrowse link 5 159,950,384 159,973,576 RGD:11554173
G Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 JBrowse link 8 33,490,280 33,519,127 RGD:11554173
RGD:8554872
G Ren renin JBrowse link 13 50,502,724 50,513,953 RGD:11554173
G Slc12a1 solute carrier family 12 member 1 JBrowse link 3 117,421,531 117,498,372 RGD:1624188
RGD:8554872
RGD:11554173
Bartter disease type 1 term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Slc12a1 solute carrier family 12 member 1 JBrowse link 3 117,421,531 117,498,372 RGD:7240710
RGD:8554872
Bartter disease type 2 term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 JBrowse link 8 33,490,280 33,519,127 RGD:7240710
RGD:8554872
Bartter disease type 3 term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Clcnka chloride voltage-gated channel Ka JBrowse link 5 159,931,497 159,946,483 RGD:8554872
G Clcnkb chloride voltage-gated channel Kb JBrowse link 5 159,950,384 159,973,576 RGD:7240710
RGD:8554872
Bartter disease type 4A term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Bsnd barttin CLCNK type accessory subunit beta JBrowse link 5 126,071,849 126,080,647 RGD:7240710
RGD:8554872
Bartter disease type 4b term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Clcnka chloride voltage-gated channel Ka JBrowse link 5 159,931,497 159,946,483 RGD:8554872
RGD:7240710
G Clcnkb chloride voltage-gated channel Kb JBrowse link 5 159,950,384 159,973,576 RGD:7240710
Bartter disease type 5 term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Maged2 MAGE family member D2 JBrowse link 5 33,174,539 33,182,715 RGD:8554872
RGD:7240710
Bartter Syndrome Type 3, with Hypocalciuria term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Clcnkb chloride voltage-gated channel Kb JBrowse link 5 159,950,384 159,973,576 RGD:8554872
Familial Hyperaldosteronism term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 JBrowse link 8 33,435,493 33,463,410 RGD:8554872
Familial Hyperaldosteronism, Type II term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Clcn2 chloride voltage-gated channel 2 JBrowse link 11 82,862,664 82,876,165 RGD:8554872
RGD:7240710
RGD:11554173
Familial Hyperaldosteronism, Type III term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 JBrowse link 8 33,435,493 33,463,410 RGD:7240710
RGD:8554872
Familial Hyperaldosteronism, Type IV term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Cacna1h calcium voltage-gated channel subunit alpha1 H JBrowse link 10 14,730,932 14,789,201 RGD:8554872
RGD:7240710
glucocorticoid-remediable aldosteronism term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 JBrowse link 7 116,248,759 116,255,205 RGD:7240710
RGD:8554872
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 JBrowse link 7 116,155,928 116,161,781 RGD:8554872
Primary Aldosteronism, Seizures, and Neurologic Abnormalities term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Cacna1d calcium voltage-gated channel subunit alpha1 D JBrowse link 16 6,110,294 6,405,022 RGD:7240710
RGD:8554872
Sensorineural Deafness with Mild Renal Dysfunction term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Bsnd barttin CLCNK type accessory subunit beta JBrowse link 5 126,071,849 126,080,647 RGD:8554872

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 15553
    disease of anatomical entity 14837
      endocrine system disease 4808
        adrenal gland disease 170
          adrenal gland hyperfunction 31
            primary hyperaldosteronism 23
              Bartter disease + 8
              Conn's syndrome 0
              Familial Hyperaldosteronism 1
              Familial Hyperaldosteronism, Type II 1
              Familial Hyperaldosteronism, Type III 1
              Familial Hyperaldosteronism, Type IV 1
              Primary Aldosteronism, Seizures, and Neurologic Abnormalities 1
              ectopic Cushing syndrome 0
              glucocorticoid-remediable aldosteronism 2
Path 2
Term Annotations click to browse term
  disease 15553
    disease of anatomical entity 14837
      endocrine system disease 4808
        adrenal gland disease 170
          adrenal cortex disease 75
            adrenal gland hyperfunction 31
              primary hyperaldosteronism 23
                Bartter disease + 8
                Conn's syndrome 0
                Familial Hyperaldosteronism 1
                Familial Hyperaldosteronism, Type II 1
                Familial Hyperaldosteronism, Type III 1
                Familial Hyperaldosteronism, Type IV 1
                Primary Aldosteronism, Seizures, and Neurologic Abnormalities 1
                ectopic Cushing syndrome 0
                glucocorticoid-remediable aldosteronism 2
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.